Theratechnologies Inc (TH):企業の財務・戦略的SWOT分析

◆英語タイトル:Theratechnologies Inc (TH) - Financial and Strategic SWOT Analysis Review
◆商品コード:GDPH81716FSA
◆発行会社(調査会社):GlobalData
◆発行日:2021年1月
◆ページ数:56
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:カナダ
◆産業分野:Pharmaceuticals and Healthcare
◆販売価格オプション(消費税別)
Site License(同一事業所内共有可)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥55,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Theratechnologies Inc (TH) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Theratechnologies Inc (Theratechnologies) is a biopharmaceutical company that focuses on the discovery and development of drugs for people with orphan medical conditions. The company’s marketed products include Egrifta (tesamorelin for injection) and Egrifta SV is indicated to reduce excess abdominal fat in human immunodeficiency virus (HIV)-infected patients with lipodystrophy; and Trogarzo, CD-4 directed post-attachment HIV-1 inhibitor indicated for HIV type 1 infection in the US. Its pipeline products include Trogarzo IV slow push for HIV and Egrifta F8 for NASH HIV.The company is also developing TH 1902 for triple negative breast cancer and TH1904 for ovarian cancer. It develops products based on peptide stabilization technology to increase target protein’s resistance to enzymatic degradation. Theratechnologies is headquartered in Montreal, Quebec, Canada.

Theratechnologies Inc Key Recent Developments

Jan 07,2021: Theratechnologies announces preliminary fourth quarter and full fiscal year 2020 revenues and provides update on R&D activities
Nov 03,2020: Theratechnologies announces departure of chief commercial officer
Oct 16,2020: Theratechnologies appoints two new board members
Oct 15,2020: Theratechnologies announces financial results for the third quarter of fiscal 2020
Sep 21,2020: Theratechnologies announces preliminary third-quarter fiscal 2020 financial results

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
List of Tables
List of Figures
Section 1 – About the Company
Theratechnologies Inc – Key Facts
Theratechnologies Inc – Key Employees
Theratechnologies Inc – Key Employee Biographies
Theratechnologies Inc – Major Products and Services
Theratechnologies Inc – History
Theratechnologies Inc – Company Statement
Theratechnologies Inc – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Company Overview
Theratechnologies Inc – Business Description
Product Category: Egrifta
Performance
Product Category: Trogarzo
Performance
Geographical Segment: Canada
Performance
Geographical Segment: The US
Performance
Theratechnologies Inc – Corporate Strategy
Theratechnologies Inc – SWOT Analysis
SWOT Analysis – Overview
Theratechnologies Inc – Strengths
Theratechnologies Inc – Weaknesses
Theratechnologies Inc – Opportunities
Theratechnologies Inc – Threats
Theratechnologies Inc – Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Performance Chart
Financial Performance
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
Theratechnologies Inc, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Theratechnologies Inc, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
Theratechnologies Inc, Recent Deals Summary
Section 5 – Company’s Recent Developments
Jan 07, 2021: Theratechnologies announces preliminary fourth quarter and full fiscal year 2020 revenues and provides update on R&D activities
Nov 03, 2020: Theratechnologies announces departure of chief commercial officer
Oct 16, 2020: Theratechnologies appoints two new board members
Oct 15, 2020: Theratechnologies announces financial results for the third quarter of fiscal 2020
Sep 21, 2020: Theratechnologies announces preliminary third-quarter fiscal 2020 financial results
Jul 15, 2020: Theratechnologies announces financial results for the second quarter of fiscal 2020
Jun 22, 2020: New data show Theratechnologies’ SORT1+ technology is effective in many treatment-resistant cancers
Apr 14, 2020: Theratechnologies announces financial results for the first quarter of 2020
Mar 31, 2020: Theratechnologies provides business update related to current covid-19 situation
Mar 02, 2020: Change to Theratechnologies management
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List of Tables
Theratechnologies Inc, Key Facts
Theratechnologies Inc, Key Employees
Theratechnologies Inc, Key Employee Biographies
Theratechnologies Inc, Major Products and Services
Theratechnologies Inc, History
Theratechnologies Inc, Other Locations
Theratechnologies Inc, Subsidiaries
Theratechnologies Inc, Key Competitors
Theratechnologies Inc, Ratios based on current share price
Theratechnologies Inc, Annual Ratios
Theratechnologies Inc, Annual Ratios (Cont...1)
Theratechnologies Inc, Annual Ratios (Cont...2)
Theratechnologies Inc, Interim Ratios
Theratechnologies Inc, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Theratechnologies Inc, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
Theratechnologies Inc, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

★海外企業調査レポート[Theratechnologies Inc (TH):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • ConceptoMed AS-医療機器分野:企業M&A・提携分析
    Summary ConceptoMed AS (ConceptoMed) is a medical device manufacturer that offers medtech products. The company's products comprise medical syringe and needle, medical tools, Luer-Jack, ConceptoShield, and disposable medical instruments and devices. ConceptoMed also offers epidural injections, plexu …
  • Ascoma Group:企業の戦略・SWOT・財務情報
    Ascoma Group - Strategy, SWOT and Corporate Finance Report Summary Ascoma Group - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • Blue Star Ltd (BLUESTARCO):企業の財務・戦略的SWOT分析
    Summary Blue Star Ltd (BSL) is an air conditioning and commercial refrigeration company that manufactures cooling products. The company’s products include room air conditioners, air purifiers, water purifiers, air coolers, water coolers, cold storages and specialty products. It also offers deep free …
  • Dynegy Inc.:戦略・SWOT・企業財務分析
    Dynegy Inc. - Strategy, SWOT and Corporate Finance Report Summary Dynegy Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • Pernod Ricard SA (RI):企業の財務・戦略的SWOT分析
    Pernod Ricard SA (RI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • American Science & Engineering, Inc.:企業の戦略・SWOT・財務情報
    American Science & Engineering, Inc. - Strategy, SWOT and Corporate Finance Report Summary American Science & Engineering, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysi …
  • Syngenta AG:企業の戦略・SWOT・財務分析
    Syngenta AG - Strategy, SWOT and Corporate Finance Report Summary Syngenta AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • Guangdong Electric Power Development Co Ltd (000539):電力:M&Aディール及び事業提携情報
    Summary Guangdong Electric Power Development Co., Ltd. (Guangdong Electric) is a leading china based electricity distribution company. The company is a subsidiary of Guangdong Yudean Group Co., Ltd. Guangdong Electric is engaged in developing electric power plants in the country. The company is also …
  • Royal DSM NV (DSM)-エネルギー分野:企業M&A・提携分析
    Summary Royal DSM NV (DSM) is a life sciences and materials sciences company, which focuses on health, nutrition and materials sectors. The company offers a wide range of products such as anti-invectives, polyesters, vitamins and other ingredients, performance materials to diverse end markets. It pr …
  • ABITEC Corp:企業の戦略的SWOT分析
    ABITEC Corp - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • PAL Holdings, Inc.:企業の戦略・SWOT・財務情報
    PAL Holdings, Inc. - Strategy, SWOT and Corporate Finance Report Summary PAL Holdings, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Mari Petroleum Co Ltd (MARI):企業の財務・戦略的SWOT分析
    Mari Petroleum Co Ltd (MARI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • AGA Rangemaster Group Ltd:企業の戦略的SWOT分析
    AGA Rangemaster Group Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • Singapore Press Holdings Limited:企業の戦略・SWOT・財務情報
    Singapore Press Holdings Limited - Strategy, SWOT and Corporate Finance Report Summary Singapore Press Holdings Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, produ …
  • ChemRar High-Tech Center:製薬・医療:M&Aディール及び事業提携情報
    Summary ChemRar High-Tech Center (CHTC) is a developer of drugs for life-threatening diseases. The company offers drugs for the treatment of cancer, central nervous system, infectious, metabolic and cardiovascular diseases. It also offers pre-clinical and clinical research of new molecules including …
  • EnergySolutions LLC:企業の戦略的SWOT分析
    EnergySolutions LLC - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and se …
  • Cummins Inc (CMI):電力:M&Aディール及び事業提携情報
    Summary Cummins Inc. (Cummins), formerly Cummins Engine Company, is a manufacturer of diesel engines and related technologies. It designs, manufactures, services and distributes engines and related component solutions. The company offers filtration, fuel systems, control systems, after treatment dev …
  • Suzuki Motor Corporation:企業の戦略・SWOT・財務分析
    Suzuki Motor Corporation - Strategy, SWOT and Corporate Finance Report Summary Suzuki Motor Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • FibroGen Inc (FGEN):企業の財務・戦略的SWOT分析
    FibroGen Inc (FGEN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • Simons Group Ltd:企業の戦略・SWOT・財務情報
    Simons Group Ltd - Strategy, SWOT and Corporate Finance Report Summary Simons Group Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆